Arp-T1 Activators encompass a range of chemical compounds that influence the activity of this actin-related protein through various cellular mechanisms. One such activator directly augments adenylate cyclase, boosting intracellular cAMP levels, and leads to the activation of protein kinase A. This kinase phosphorylates specific targets, facilitating the assembly of Arp-T1 into actin structures. Another activator, a known promoter of protein kinase C, phosphorylates substrates that play a role in actin polymerization, thereby potentially enhancing the function of Arp-T1 within the cytoskeleton. Additionally, compounds that stabilize actin filaments or disrupt actin polymerization can lead to compensatory cellular responses that increase Arp-T1 activity. These responses may include the upregulation of actin nucleation processes or the activation of mechanisms that stabilize actin filaments, in which Arp-T1 is a critical participant.
Furthermore, inhibitors that target protein phosphatases can lead to a heightened state of phosphorylation in cellular proteins associated with actin dynamics, thereby potentially amplifying Arp-T1 activity. Compounds that interfere with the binding and polymerization of actin monomers or sever actin filaments can also trigger indirect activation of Arp-T1 as the cell strives to maintain cytoskeletal integrity. Additionally, modulation of actin-myosin interactions through the inhibition of kinases involved in contractility can lead to an environment conducive to Arp-T1-mediated actin filament formation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Direct adenylate cyclase activator, increasing cAMP levels, which can enhance Arp-T1 assembly into filamentous actin structures via PKA-dependent phosphorylation events. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activator of protein kinase C (PKC) which phosphorylates downstream targets that can affect actin polymerization, potentially increasing Arp-T1 activity within the cytoskeleton. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $180.00 $299.00 | 59 | |
Stabilizes filamentous actin and can indirectly increase Arp-T1 activity by promoting actin polymerization and subsequent nucleation. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $260.00 $799.00 | 36 | |
Binds to actin monomers preventing polymerization, this disruption can lead to compensatory mechanisms that activate Arp-T1 to stabilize actin filaments. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
Inhibitor of protein phosphatases 1 and 2A, which can lead to increased phosphorylation of proteins involved in actin dynamics, potentially enhancing Arp-T1 activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Inhibits protein phosphatases leading to increased phosphorylation within the cell, and may enhance Arp-T1 activity by altering the actin cytoskeleton. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
Binds to the barbed end of actin filaments, preventing further polymerization and potentially activating compensatory nucleation activity of Arp-T1. | ||||||
Swinholide A, Theonella swinhoei | 95927-67-6 | sc-205914 | 10 µg | $135.00 | ||
Severs actin filaments which could indirectly trigger Arp-T1 activation as a response to maintain cytoskeletal integrity. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $88.00 $311.00 | 17 | |
Inhibitor of PKC, leading to altered phosphorylation states of actin-associated proteins, which may indirectly activate Arp-T1. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $89.00 $262.00 | 13 | |
Inhibitor of myosin light chain kinase (MLCK), altering actin-myosin interaction and possibly leading to increased Arp-T1 activity in actin filament stabilization. |